Key result
Platelet aggregation was normal in coagulation factor deficiencies and thrombosis, but impaired in specific platelet defects, uraemia, and certain leukaemias.
Why the study?
Does the rate of platelet aggregation differ between healthy subjects and patients with haemorrhagic disease or thrombosis?
Observational
Does the rate of platelet aggregation differ between healthy subjects and patients with haemorrhagic disease or thrombosis?
The study demonstrates that impaired platelet aggregation is associated with specific platelet or plasma defects rather than coagulation factor deficiencies, and finds no evidence of increased aggregation in arterial or venous thrombosis.
Answers are grounded in this paper and cite their sources.
Supports selective aggregation testing in suspected platelet disorders; leaves open its value in thrombosis and requires prospective validation.
The degree of platelet aggregation in healthy subjects, haemorrhagic disease and thrombosis has been studied by means of two techniques. Firstly, using a small cone in cone viscometer at high rates of shear, an artificial in vitro thrombus was obtained which represents aggregation of platelets during the process of coagulation. Secondly, a turbidiometric method measuring the fall in optical density during aggregation of platelets was used to record the rate of platelet cohesion in the presence of adenosine diphosphate (ADP) or thrombin. There was rough correlation between the effects of thrombin and ADP on the rate of aggregation in various normal subjects suggesting that the mechanism in the presence of these two substances was similar. The rate of platelet aggregation was observed weekly in ten normal females and no change occurred at the onset of menstruation. Platelet aggregation was found normal in factor VIII deficiency, factor IX deficiency, moderate factor VII deficiency, hypofibrinogenaemia as well as in patients on phenindione or heparin. Impaired aggregation was due to a specific platelet defect in some leukaemias, reticuloses, uraemia as well as two cases of Glanzmann's disease. The defect in aggregation in Waldenström's macroglobulinaemia and fibrinolysis appeared to be due to a plasma factor. Our present method of study did not reveal any abnormality in two cases of von Willebrand's disease and appear insensitive to lack of “Anti‐Willebrand factor”. The study of patients with arterial or venous thrombosis produced values wholly within the normal range and no evidence for a state of “increased tendency to aggregation” was obtained.
No takes yet. Share an insight, caveat, or question.
OZENBERG et al. (1966) conducted an observational in Haemorrhagic disease and thrombosis. Haemorrhagic disease and thrombosis vs. Healthy subjects was evaluated on Rate of platelet aggregation. Platelet aggregation was normal in coagulation factor deficiencies and thrombosis, but impaired in specific platelet defects, uraemia, and certain leukaemias.
Synapse has enriched 10 related papers. Consider them for comparative context: